Hepatitis B Immunoglobulin (HBIG) Dosing Recommendations
The recommended intramuscular HBIG dose is 0.06 mL/kg for adults and children ≥10 kg after acute exposure, 0.5 mL for newborns of HBsAg-positive mothers (given within 12 hours of birth), and the same weight-based or fixed dosing applies to immunocompromised patients and those with chronic liver disease following exposure. 1
Newborns of HBsAg-Positive Mothers
For infants born to HBsAg-positive mothers, administer 0.5 mL HBIG intramuscularly within 12 hours of birth at a separate anatomical site from the hepatitis B vaccine 2, 1. This timing is critical—efficacy decreases markedly if delayed beyond 48 hours 1. The combination of HBIG plus vaccine series is 85-95% effective in preventing chronic HBV carrier state, compared to only 50% efficacy with HBIG alone 1.
Special Considerations for Low Birth Weight:
- Infants <2,000 grams with HBsAg-positive mothers: Still receive 0.5 mL HBIG at birth, but the birth vaccine dose doesn't count toward the series—give 4 total vaccine doses starting at 1 month of age 2
- Infants <2,000 grams with unknown maternal status: Give both HBIG (0.5 mL) and vaccine within 12 hours if maternal status cannot be determined 2
Adults and Children ≥10 kg (Acute Exposure)
For percutaneous, ocular, or mucous membrane exposure to HBsAg-positive blood, administer 0.06 mL/kg intramuscularly as soon as possible, ideally within 24 hours 1. The value of HBIG beyond 7 days post-exposure is unclear 1. This applies to:
- Needlestick injuries
- Bite exposures
- Accidental splash to mucous membranes
- Oral ingestion (pipetting accidents)
The two-dose HBIG regimen (at exposure and 1 month later) without vaccine is approximately 75% effective, but combining HBIG with the vaccine series is superior and the treatment of choice 1.
Sexual Exposure to HBsAg-Positive Person
Administer 0.06 mL/kg intramuscularly within 14 days of last sexual contact, combined with initiation of the hepatitis B vaccine series 1. Single-dose HBIG is 75% effective if given within 2 weeks of exposure 1.
Household Exposure (Infants <12 Months)
For infants <12 months exposed to a primary caregiver with acute hepatitis B, give 0.5 mL HBIG plus initiate vaccine series 1. Other household contacts only need prophylaxis if they had identifiable blood exposure (e.g., sharing toothbrushes or razors)—treat these as sexual exposures with 0.06 mL/kg dosing 1.
Patients with Chronic Liver Disease or Immunocompromise
The guidelines do not specify different HBIG dosing for immunocompromised patients or those with chronic liver disease after acute exposure. Use the standard 0.06 mL/kg dose for post-exposure prophylaxis 1. These patients are listed as priority groups for hepatitis B vaccination 2, but when acute exposure occurs, follow the same weight-based dosing algorithm as immunocompetent adults.
Critical Timing Considerations:
- Newborns: Within 12 hours (preferably), no later than 48 hours 1
- Acute exposure: Within 24 hours, questionable benefit after 7 days 1
- Sexual exposure: Within 14 days of last contact 1
Common Pitfalls to Avoid:
- Do not delay HBIG while awaiting maternal HBsAg results in newborns—if status unknown and infant ≥2,000 grams, give vaccine immediately; if <2,000 grams, give both HBIG and vaccine 2
- Do not administer HBIG intravenously—it must be given intramuscularly 1
- Do not give HBIG and vaccine at the same injection site—use separate anatomical sites (e.g., different limbs) 2, 1
- For persons refusing vaccine, repeat HBIG at 1 month (and at 3 and 6 months for newborns) 1